Bosh sahifaME • NASDAQ
23andMe Holding Co.
3,11 $
Seans yopilganidan keyin:
3,22 $
(3,54%)+0,11
Yopilgan:22-noy, 18:26:25 (GMT-5) · USD · NASDAQ · Ogohlantirish
AksiyalarAQSH qimmatli qogʻoziBosh shtabi: AQSH
Yopilish kursi
3,23 $
Kunlik diapazon
2,99 $ - 3,21 $
Yillik diapazon
2,66 $ - 20,20 $
Bozor kapitalizatsiyasi
74,94 mln USD
Oʻrtacha hajm
404,88 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)sen, 2024Y/Y qiyosi
Daromad
44,07 mln-11,86%
Joriy xarajat
81,33 mln-17,18%
Sof foyda
-59,10 mln21,48%
Sof foyda marjasi
-134,1110,91%
Har bir ulushga tushum
EBITDA
-54,96 mln21,06%
Amaldagi soliq stavkasi
0,07%
Jami aktivlari
Jami passivlari
(USD)sen, 2024Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
126,60 mln-50,62%
Jami aktivlari
318,94 mln-60,19%
Jami passivlari
217,01 mln23,31%
Umumiy kapital
101,93 mln
Tarqatilgan aksiyalar
26,12 mln
Narxi/balansdagi bahosi
0,82
Aktivlardan daromad
-42,89%
Kapitaldan daromad
-75,30%
Naqd pulning sof oʻzgarishi
(USD)sen, 2024Y/Y qiyosi
Sof foyda
-59,10 mln21,48%
Operatsiyalardan naqd pul
-40,93 mln28,34%
Sarmoyadan naqd pul
-2,70 mln2,63%
Moliyadan naqd pul
260,00 ming-83,68%
Naqd pulning sof oʻzgarishi
-43,37 mln25,18%
Boʻsh pul
-12,82 mln59,90%
Haqida
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Tashkil etilgan
apr 2006
Xodimlar soni
571
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu